MC3R Antibody, FITC conjugated

Shipped with Ice Packs
In Stock

Description

Introduction to MC3R Antibody, FITC Conjugated

The MC3R antibody, FITC conjugated is a fluorescently labeled immunological reagent designed to detect the melanocortin-3 receptor (MC3R), a G-protein-coupled receptor (GPCR) critical for energy homeostasis and anti-inflammatory signaling. FITC (fluorescein isothiocyanate) is a green-emitting fluorescent dye conjugated to the antibody, enabling visualization via fluorescence microscopy, flow cytometry, or immunofluorescence assays. This antibody is widely used in research to study MC3R’s role in metabolic regulation, obesity, and immune responses.

Applications in Research

MC3R-FITC antibodies are employed in diverse experimental workflows:

Immunohistochemistry (IHC)

  • Tissue Localization: Used to detect MC3R in brain, adipose tissue, and macrophages. For example, IHC protocols often require antigen retrieval (e.g., TE buffer pH 9.0) for optimal staining .

  • Example: Proteintech’s MC3R antibody (21027-1-AP) shows positive staining in mouse brain and human small intestine tissues .

Western Blotting (WB)

  • Protein Validation: Confirms MC3R expression in lysates. Thermo Fisher’s MC3R antibody detects a ~36 kDa band in K562 cell lysates .

  • Optimal Dilution: Typically 1:100–1:1,000 .

Immunofluorescence (IF)

  • Subcellular Localization: FITC-conjugated antibodies enable live-cell imaging or fixed-cell analysis. MC3R localizes apically in polarized MDCK cells, as shown in studies using anti-MC3R antibodies .

Flow Cytometry (FC)

  • Cell Surface Detection: RayBiotech’s anti-MC3R (Center) antibody is validated for FC, with FITC-conjugated secondary antibodies used for signal amplification .

Role in Energy Regulation

  • MC3R Deficiency: Mice lacking MC3R exhibit increased adiposity despite reduced food intake, highlighting its role in peripheral energy expenditure .

  • Anti-Inflammatory Effects: MC3R expressed in macrophages suppresses pro-inflammatory cytokines, modulating cardiac and metabolic inflammation .

Translation and Localization

  • Alternative Splicing: A 5′ exon directs translation initiation at the second ATG, producing a 323-amino acid protein. Mutations disrupting this process lead to cytoplasmic mislocalization .

  • Apical Membrane Targeting: In polarized cells, MC3R colocalizes with apical markers like CFTR, suggesting a role in nutrient-sensing pathways .

Obesity and Metabolic Disorders

  • Genetic Links: MC3R variants are associated with obesity susceptibility in humans. Antibodies aid in mapping receptor distribution in adipose tissue and hypothalamic regions .

Technical Considerations

ParameterRecommendationSource
Storage-20°C to -80°C; avoid light exposure for FITC
DilutionOptimize for each assay (e.g., 1:50–1:500 for IHC)
ControlsUse isotype-matched IgG-FITC to exclude nonspecific binding

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship your order within 1-3 business days of receiving it. Delivery time may vary depending on the shipping method and destination. Please contact your local distributor for specific delivery timeframes.
Synonyms
MC3R; Melanocortin receptor 3; MC3-R
Target Names
Uniprot No.

Target Background

Function
The Melanocortin 3 Receptor (MC3R) acts as a receptor for Melanocyte-Stimulating Hormone (MSH) variants (alpha, beta, and gamma) as well as Adrenocorticotropic Hormone (ACTH). This receptor is coupled to G proteins, which in turn activate adenylate cyclase. MC3R plays a crucial role in the expression of anticipatory activity and wakefulness patterns during periods of limited nutrient availability and in the normal regulation of circadian clock activity in the brain.
Gene References Into Functions
  1. This review summarizes the identified MC3R polymorphisms and mutations in humans, along with in vitro, murine, and human cohort studies investigating their potential effects. Certain human MC3R mutations have been linked to increased adiposity and hyperleptinemia. [review] PMID: 28363697
  2. This study provides structural insights into the selective ligand-receptor interactions leading to receptor inactivation, utilizing selective Melanocortin 3 Receptor antagonists. PMID: 28715181
  3. MC3R mutations have been associated with obesity. PMID: 27288827
  4. This research suggests that MC3R genetic variants play a role in adiposity gain during early childhood. PMID: 26663875
  5. No evidence of an association between MC3R variations and obesity has been found. PMID: 26782456
  6. Replacing the murine Mc3r with a double-mutant (C17A+G241A) human MC3R resulted in increased weight and fat mass, along with elevated energy intake and feeding efficiency. PMID: 26818770
  7. The DPLIY motif and helix 8 were found to be crucial for MC3R activation and signal transduction. This study provided a deeper understanding of the structure-function relationship of MC3R. PMID: 26220347
  8. This research provides novel data on the structure-function relationship of MC3R, identifying residues essential for receptor function. Some of the studied mutations exhibited biased signaling, preferentially activating one intracellular signaling pathway. PMID: 25798062
  9. This study proposed three potential human candidate genes for voluntary physical exercise levels: MC3R, CYP24A1, and GRM8. PMID: 24821406
  10. The cytoplasmic end of transmembrane domain 3 and the intracellular loop 2 were identified as critical for MC3R function. PMID: 25228159
  11. MC3R polymorphism shows a marginal association with the development of pulmonary tuberculosis in the Korean population. PMID: 25064630
  12. MC3R is a 2-exon gene requiring a 5' UTR for translation, localization, and potential interaction with MRAP2. PMID: 25051171
  13. 3' RACE experiments using MC3R transcripts indicated that the 3' UTR terminates approximately 115-160 bases after the translational stop codon. PMID: 25450386
  14. This study focused on the search for MC3R polymorphism in the Polish population. PMID: 24142065
  15. The total prevalence of rare MC3R variants in Belgian obese children and adolescents was found to be 1% compared to 1.02% in lean controls. PMID: 23264184
  16. This research suggests that the MC3R rs6127698 polymorphism is associated with pulmonary tuberculosis in a sample of the Iranian population. PMID: 23827504
  17. Data suggest that specific amino acid residues (M247, R252, H254, K256, R257, A259) in the 3rd intracellular loop (ICL3) of MC3R are important for ligand binding and signal transduction. These studies used mutant, recombinant MC3R expressed in the HEK293T cell line. PMID: 23323615
  18. While MC3R mutations are unlikely to result in an autosomal dominant form of monogenic obesity due to the lack of strong cosegregation in family studies, these studies provide evidence that MC3R can contribute to increased adiposity. [review] PMID: 23280863
  19. These findings suggest that MC3R rs6127698 does not have a direct role in tuberculosis susceptibility. However, the possibility remains that this polymorphism is linked to an adjacent functional genetic variant, acting as a surrogate marker for disease risk. PMID: 23497691
  20. This study provides detailed data on novel human MC3R mutations, leading to a better understanding of the structure-function relationship of MC3R and its role in obesity. PMID: 22884546
  21. Interaction between the melanocortin 3 receptor (MC3R) and the growth hormone secretagogue receptor (GHSR)-1a results in a modulation of function in both receptors. PMID: 22327910
  22. The T6K polymorphism is not located in the coding region of the human MC3R and has no influence on translation initiation, making an impact on body weight unlikely. PMID: 22433616
  23. Carriers of the MC3R 6Lys-81Ile haplotype exhibited higher respiratory quotient and higher glucose oxidation compared to non-carriers after standardization for fat-free mass. PMID: 21983807
  24. Extracellular cysteine residues C305, C311, and C313 are crucial for receptor expression, while transmembrane cysteine residues C115 and 162 are essential for ligand binding and signaling. PMID: 22079958
  25. In the populations studied, functionally significant MC3R variants are associated with obesity. PMID: 21047972
  26. This study provided sufficient evidence to support that there is no major effect of genetic variants of MC3R on differential weight loss. PMID: 21695122
  27. This research demonstrated that MC3R polymorphisms have a protective effect on metabolic traits. PMID: 21920079
  28. Polymorphisms in the MC3R promoter and CTSZ 3'UTR have been associated with tuberculosis susceptibility. PMID: 21368909
  29. This study suggests a role of the MC3R gene in the pathogenesis of obesity in a small subset of patients. PMID: 20539302
  30. While MC3R is an important regulator of energy homeostasis, mutations in the MC3R gene remain controversially associated with human obesity pathogenesis. [Review] PMID: 20882712
  31. These data are consistent with the involvement of rs3746619 in weight regulation among obese individuals. PMID: 20972733
  32. There is insufficient evidence to support the contribution of common melanocortin-3 receptor variants to childhood obesity. However, our results are concordant with a role of melanocortin-3 receptor variants in some dimensions of eating behavior. PMID: 20144537
  33. This study identified a novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. PMID: 11889220
  34. This study observed an association between an insertion polymorphism and fat mass, percent body fat, and total abdominal fat. PMID: 12142547
  35. This study investigated a variation in a Maori kindred with obesity and early onset type 2 diabetes. PMID: 12161058
  36. This research conducted a functional characterization of the I183N mutated MC3R compared to the wild-type MC3R after transfection in HEK293 cells. PMID: 15276649
  37. MC3R mutations may be a genetic factor that confers susceptibility to obesity, likely due to haploinsufficiency. This study identified a residue that is critical for the activation of G protein-coupled receptors. PMID: 15292330
  38. Single-nucleotide polymorphisms were found in anorexia nervosa. PMID: 16314751
  39. This study demonstrated that TM3 and TM6 are important for NDP-MSH binding, while D121 in TM2 and D332 in TM7 are crucial for receptor activity and signaling. These findings provide molecular determinants of hMC3R responsible for ligand binding and receptor signals. PMID: 16430209
  40. In addition to its inverse agonistic activities, Agrp exhibits agonistic properties on the endocytosis pathway of melanocortin-3 and -4 receptors. PMID: 17041250
  41. This study suggests that SNPs of MC3R may regulate substrate oxidation and first-phase insulin secretion. PMID: 17192297
  42. These results suggest a gene-diet interaction between the MC3R C17A and G241A variants and a weight loss program for the ability to lose weight in childhood obesity. PMID: 17413091
  43. This study explored the structure-activity of lactam derivatives of MT-II and SHU-9119 at MC3R. PMID: 17482720
  44. MC3R mutations may not cause autosomal dominant forms of obesity but could contribute as a predisposing factor to childhood obesity. PMID: 17639020
  45. The highly conserved N/DPxxY motif was found to be critical for multiple aspects of MC3R function, including cell surface expression, ligand binding, and signaling. PMID: 17964765
  46. In the Maori kindred, the D20S32e polymorphism is significantly associated with insulin resistance but not with the metabolic syndrome. PMID: 18180070
  47. In humans, MC3R mutations may be a cause of dominantly inherited obesity. PMID: 18231126
  48. This study indicates a link between MC3R and cell growth pathways that may involve the alteration of AKT signaling pathways. PMID: 18291523
  49. This research suggests that the MC3R gene is unlikely to play a major role in tuberculosis susceptibility in African populations. PMID: 18420963
  50. This study demonstrated that acidic residues in transmembrane (TM) domains 1 and 3 are important for ligand binding, whereas the acidic residues in TMs 2 and 7 are important for both ligand binding and signaling. PMID: 18614155

Show More

Hide All

Database Links

HGNC: 6931

OMIM: 155540

KEGG: hsa:4159

STRING: 9606.ENSP00000243911

UniGene: Hs.248018

Protein Families
G-protein coupled receptor 1 family
Subcellular Location
Cell membrane; Multi-pass membrane protein.
Tissue Specificity
Brain, placental, and gut tissues.

Q&A

What is MC3R and why is it an important research target?

MC3R (Melanocortin-3 Receptor) is a G-protein coupled receptor that plays an essential role in energy homeostasis. It belongs to the melanocortin receptor family and has been implicated in obesity in both humans and mice . MC3R is composed of two exons that are spliced to form an mRNA of approximately 1363 bp in primary brain tissue and pulmonary airway epithelial cells . Recent structural studies revealed that the full-length protein encompasses 323 amino acids, with translation initiating from the second in-frame ATG codon .

The importance of MC3R as a research target stems from its function as a canonical MSH receptor involved in metabolic regulation. Studies of MC3R variants have demonstrated its significance in understanding energy metabolism pathways and obesity mechanisms. Unlike related receptors such as MC4R, MC3R has unique localization patterns in polarized cells, typically presenting at the apical membrane, which suggests specialized signaling functions .

What are the optimal working dilutions for MC3R antibody applications?

The optimal working dilutions for MC3R antibodies vary depending on the specific application. For FITC-conjugated rabbit polyclonal antibodies against MC3R:

ApplicationRecommended DilutionNotes
ELISA1:10,000Higher dilutions may be tested to optimize signal-to-noise ratio
Western Blot1:500May require optimization based on protein expression levels
Dot Blot1:10,000For rapid detection of MC3R in samples
ImmunofluorescenceNot specified in dataStarting dilution of 1:200-1:500 recommended for testing

These dilutions serve as starting points and should be optimized for each experimental system . When working with new batches of antibody or different tissue/cell types, a dilution series is recommended to determine optimal working conditions.

How should FITC-conjugated MC3R antibodies be stored to maintain functionality?

FITC-conjugated MC3R antibodies should be stored at -20°C for long-term preservation of fluorescent activity and antibody functionality . These antibodies are typically supplied at a concentration of 0.55 μg/μl in antibody stabilization buffer, which helps maintain their structure and binding capacity .

To preserve fluorescence intensity and prevent photobleaching, always:

  • Store in small aliquots to avoid repeated freeze-thaw cycles

  • Protect from light exposure by wrapping in aluminum foil or using amber tubes

  • When working with the antibody, minimize exposure to bright light sources

  • Avoid prolonged periods at room temperature

  • Check for precipitation before use and centrifuge if necessary

The excitation wavelength for FITC is 490nm, with emission at 525nm, which should be considered when designing experiments with multiple fluorophores to avoid spectral overlap .

What species reactivity can be expected from commercially available MC3R antibodies?

Commercial MC3R antibodies, including FITC-conjugated versions, typically demonstrate cross-reactivity with multiple species due to the conserved nature of the MC3R protein sequence. Available FITC-conjugated rabbit polyclonal antibodies to MC3R show reactivity against human, mouse, and rat MC3R .

  • The degree of reactivity may vary between species

  • Validation in the specific species of interest is recommended prior to extensive studies

  • The immunogen used for antibody production is typically a synthetic peptide corresponding to unique amino acid sequences on the MC3R protein

  • Epitope accessibility may differ depending on experimental conditions and sample preparation methods

How can researchers verify the specificity of MC3R antibodies in their experimental systems?

Verifying antibody specificity is crucial for reliable research outcomes. For MC3R antibodies, several approaches are recommended:

Positive and negative controls:

  • Use cell lines with known MC3R expression (positive control) versus those lacking MC3R (negative control)

  • Include MC3R knockout tissue/cells where available

  • Compare staining patterns to published literature on MC3R localization

Comparative analysis with other detection methods:

  • Correlation with mRNA expression (qRT-PCR)

  • Validation using multiple antibodies targeting different epitopes

  • Complementary detection using tagged MC3R constructs

Blocking experiments:

  • Pre-incubate the antibody with the immunizing peptide to confirm signal reduction

  • Competition assays with unlabeled antibody

In polarized cell systems, MC3R should display discrete apical and subapical localization, as demonstrated in polarized MDCK cells . Aberrant cytoplasmic staining patterns may indicate cross-reactivity or detection of alternative translation products. The discovery that MC3R has a 5' exon that directs translation from a second in-frame ATG is important for interpreting staining patterns, as proteins synthesized from the first ATG have been shown to localize diffusely in the cytoplasm rather than at the membrane .

What methodological approaches are recommended for optimizing immunofluorescence protocols with FITC-conjugated MC3R antibodies?

Optimizing immunofluorescence protocols for FITC-conjugated MC3R antibodies requires careful attention to several parameters:

Sample preparation:

  • Fixation method significantly impacts epitope preservation; compare 4% paraformaldehyde (PFA) with methanol fixation to determine optimal conditions

  • For polarized cells, maintain cell polarity during processing to preserve MC3R localization at the apical membrane

  • Use membrane markers (like ZO-1 for tight junctions) to provide spatial context for MC3R localization

Antigen retrieval and permeabilization:

  • Test graded concentrations of detergents (0.1-0.5% Triton X-100 or 0.1-0.3% saponin) to balance membrane permeabilization with epitope preservation

  • Consider antigen retrieval methods for fixed tissue sections

Signal amplification and background reduction:

  • Use blocking solutions containing serum from the same species as secondary antibodies

  • Consider tyramide signal amplification for low-abundance targets

  • Include autofluorescence quenching steps for tissues with high endogenous fluorescence

Co-localization studies:

  • When co-staining with other markers, use GFP-tagged proteins like CFTR to mark the apical membrane for proper localization assessment

  • Select fluorophores with minimal spectral overlap to avoid bleed-through

MC3R primarily localizes to the apical membrane in polarized cells, with occasional subapical distribution . This distinct localization pattern provides a useful validation criterion for antibody specificity and proper sample preparation.

What are the challenges in detecting different translational variants of MC3R and how can they be addressed?

Research has revealed that MC3R translation can initiate from different ATG codons, resulting in protein variants with distinct cellular localizations . This presents significant challenges for antibody-based detection:

Challenges:

  • The full-length MC3R with the 5' UTR directs translation from the second in-frame ATG, resulting in a 323-amino acid protein that localizes to the apical membrane

  • Without the 5' UTR, translation initiates at the first ATG, producing a protein with diffuse cytoplasmic distribution

  • Commercial antibodies may have varying affinities for these different translational variants

Methodological solutions:

  • Use epitope-mapped antibodies that specifically recognize regions present in the desired variant

  • Combine with genetic approaches using tagged constructs that express specific variants

  • Perform parallel Western blot analysis to identify protein bands of different molecular weights corresponding to translation from different ATG codons

  • When studying MC3R localization, include membrane markers and conduct z-stack confocal imaging to clearly distinguish membrane from cytoplasmic staining

Experimental validation approach:

  • Transfect cells with constructs containing or lacking the 5' UTR of MC3R

  • Compare localization patterns using both the antibody of interest and epitope tags

  • Verify results with functional assays measuring MC3R signaling

  • Use site-directed mutagenesis of ATG codons to confirm translational start sites

Understanding these translational differences is critical when interpreting results, as many published studies have utilized constructs corresponding to partial MC3R (parMC3R) that may not represent the physiologically relevant protein .

How can MC3R antibody-based assays be integrated with functional studies of melanocortin signaling?

Integrating MC3R antibody-based detection with functional studies provides a more comprehensive understanding of melanocortin signaling:

Correlative microscopy and signaling analysis:

  • Combine immunofluorescence detection of MC3R with calcium imaging or cAMP assays

  • Monitor receptor internalization following agonist stimulation

  • Assess co-localization with signaling partners using proximity ligation assays

Receptor trafficking studies:

  • Track MC3R movement in response to agonists/antagonists using live-cell imaging

  • Quantify surface expression versus internalized receptor pools

  • Study the impact of obesity-associated variants on receptor trafficking and localization

Mechanistic investigation of protein interactions:

  • Investigate the relationship between MC3R and accessory proteins like melanocortin receptor accessory proteins (MRAPs)

  • Research shows that MC3R expression causes relocalization of melanocortin receptor accessory protein 2 to the apical membrane, coincident with MC3R localization

  • Use co-immunoprecipitation followed by Western blotting to confirm physical interactions

Functional validation in polarized systems:

  • Establish polarized cell models with endogenous or exogenous MC3R expression

  • Compare signaling outputs from apical versus basolateral stimulation

  • Correlate receptor localization with signaling efficiency

These integrative approaches help establish the relationship between MC3R expression, localization, and function, particularly in understanding how obesity-associated variants might impact receptor signaling.

What are common issues encountered with FITC-conjugated antibodies and how can they be resolved?

FITC-conjugated antibodies present specific technical challenges that can impact experimental outcomes:

Photobleaching:

  • FITC is more prone to photobleaching than other fluorophores

  • Use anti-fade mounting media containing p-phenylenediamine or propyl gallate

  • Minimize exposure to excitation light during imaging

  • Consider sequential rather than simultaneous scanning in confocal microscopy

pH sensitivity:

  • FITC fluorescence is optimal at pH 8.0 and decreases in acidic environments

  • Buffer sample preparation solutions appropriately (pH 7.2-8.0)

  • Be cautious when studying acidic cellular compartments

Autofluorescence interference:

  • Tissue autofluorescence often overlaps with FITC emission spectrum

  • Include unstained controls to determine background levels

  • Consider spectral unmixing during image analysis

  • Use Sudan Black B (0.1-0.3%) treatment to reduce autofluorescence

Signal fading during long-term storage:

  • Store slides at -20°C for longer preservation

  • Seal edges of coverslips with nail polish to prevent oxidation

  • Image critical samples promptly after staining

Fluorophore-to-protein ratio issues:

  • Over-conjugation can lead to fluorescence quenching and reduced antibody affinity

  • Commercial FITC-conjugated MC3R antibodies should have optimized conjugation ratios

  • Validating different lots is recommended for critical experiments

How should researchers approach quantification of MC3R expression in complex tissue samples?

Quantifying MC3R expression in complex tissues requires systematic approaches to ensure accuracy and reproducibility:

Sample preparation considerations:

  • Standardize tissue collection, fixation, and processing protocols

  • Include positive controls (brain tissues with known MC3R expression) and negative controls

  • Process all experimental samples simultaneously to minimize technical variation

Imaging parameters for quantification:

  • Establish consistent acquisition settings (exposure time, gain, laser power)

  • Define threshold values based on control samples

  • Use z-stack imaging to capture the full depth of expression

  • Employ tile scanning for heterogeneous tissue sections

Quantification methods and analysis:

  • For membrane-localized MC3R, measure fluorescence intensity along membrane segments rather than whole-cell intensity

  • When comparing expression levels, normalize to membrane markers or cell numbers

  • Use automated image analysis software with consistent parameters

  • Report relative rather than absolute expression levels unless using calibrated standards

Validation approaches:

  • Correlate protein expression with MC3R mRNA levels using in situ hybridization or qRT-PCR

  • Verify key findings with orthogonal methods such as flow cytometry for single-cell suspensions

  • Consider Western blotting for total protein quantification, recognizing that the second in-frame ATG is the primary translation start site

When quantifying MC3R in polarized cells, account for its discrete localization patterns at apical membranes or in subapical compartments, as mistaking these distributions could lead to misinterpretation of expression levels .

How can FITC-conjugated MC3R antibodies be utilized in high-content screening and multi-parametric analysis?

High-content screening and multi-parametric analysis with FITC-conjugated MC3R antibodies enable more comprehensive understanding of melanocortin system regulation:

Multi-parameter imaging approaches:

  • Combine MC3R detection with markers for subcellular compartments (endoplasmic reticulum, Golgi, endosomes)

  • Include readouts for activation state (phosphorylation-specific antibodies)

  • Co-stain for downstream signaling molecules or interacting proteins

  • Utilize nuclear markers to normalize cell counts

Automated high-content analysis:

  • Develop analysis pipelines that quantify:

    • Membrane/cytoplasmic distribution ratios

    • Co-localization coefficients with interacting partners

    • Morphological features of MC3R-expressing cells

    • Population heterogeneity in expression levels

Application to drug discovery:

  • Screen for compounds that modulate MC3R trafficking or localization

  • Evaluate receptor internalization kinetics following agonist exposure

  • Assess the impact of potential therapeutic compounds on MC3R-MRAP interactions

  • Study competition between antibodies and drug candidates for receptor binding

Integration with single-cell approaches:

  • Use imaging flow cytometry to correlate MC3R localization with other cellular parameters

  • Combine with single-cell transcriptomics to link receptor expression with gene signatures

  • Develop spatial transcriptomics approaches to map MC3R protein expression to local gene expression environments

These advanced applications can significantly enhance our understanding of MC3R biology in normal physiology and disease states, particularly in the context of obesity research.

What considerations are important when designing co-localization studies with MC3R and other proteins?

Co-localization studies provide valuable insights into MC3R interactions and functional relationships, but require careful methodological consideration:

Selection of protein partners:

  • Melanocortin receptor accessory proteins (MRAPs) are logical co-localization candidates as research shows MC3R causes relocalization of MRAP2 to the apical membrane

  • Signaling molecules in the cAMP pathway

  • Other G-protein coupled receptors that might form heterodimers

  • Trafficking machinery components

Technical parameters for valid co-localization:

  • Optical resolution limits must be considered (lateral resolution ~200-250 nm, axial resolution ~500-700 nm in standard confocal microscopy)

  • Super-resolution techniques may be required for definitive co-localization at the molecular level

  • Antibody penetration depth must be consistent between targets

  • Sequential scanning rather than simultaneous acquisition reduces bleed-through

Quantitative co-localization metrics:

  • Calculate Pearson's correlation coefficient, Manders' overlap coefficient, or object-based co-localization

  • Perform appropriate controls including single-stained samples and randomly scrambled images

  • Set thresholds based on biological rationale rather than visual appearance

Biological validation of co-localization:

  • Complement imaging with functional assays (FRET, BRET, PLA)

  • Perform co-immunoprecipitation to confirm physical interactions

  • Use split-reporter assays for direct protein-protein interaction verification

  • Employ genetic approaches (knockdown/knockout) to assess dependency of localization patterns

When studying MC3R in polarized cells, markers for apical (e.g., CFTR) and basolateral domains, as well as tight junctions (ZO-1), provide essential spatial context for interpreting co-localization patterns .

What emerging technologies might enhance MC3R research using antibody-based approaches?

Several cutting-edge technologies hold promise for advancing MC3R research beyond current capabilities:

Advanced imaging technologies:

  • Super-resolution microscopy techniques (STORM, PALM, STED) to resolve nanoscale organization of MC3R within membrane microdomains

  • Expansion microscopy to physically enlarge samples for improved spatial resolution

  • Lattice light-sheet microscopy for rapid 3D imaging of MC3R trafficking in living cells

  • Cryo-electron tomography to visualize MC3R in its native membrane environment

Next-generation antibody technologies:

  • Development of nanobodies against MC3R for improved penetration and reduced spatial displacement

  • Site-specific conjugation methods to maintain antibody affinity while adding fluorophores

  • Bi-specific antibodies to simultaneously target MC3R and interacting partners

  • Photoactivatable antibodies for selective labeling and tracking

Integration with -omics approaches:

  • Combining MC3R immunoprecipitation with mass spectrometry to identify the receptor interactome

  • Spatial proteomics to map MC3R distribution across tissue microenvironments

  • Single-cell analysis correlating MC3R protein levels with transcriptional signatures

  • Proximity labeling approaches (BioID, APEX) to identify proteins in the MC3R microenvironment

Functional genomics integration:

  • CRISPR-mediated knock-in of fluorescent tags at the endogenous MC3R locus

  • Optogenetic control of MC3R trafficking combined with antibody-based detection

  • Live-cell biosensors to correlate MC3R localization with real-time signaling outputs

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.